Research background: At present, gastric cancer or gastric malignant tumors seriously endanger the health of human beings around the world. The main reason is that this do not have enough understanding of stomach cancer and gastric malignant tumors. Don't attach importance to health education. Helicobacter pylori treatment is incomplete, and it is clearly pointed out in the guidelines that some asymptomatic Helicobacter pylori infection do not need treatment. Our prevention measures for gastric cancer and gastric malignant tumors and the promotion of risk factors are insufficient, and the early screening of gastric cancer and gastric malignant tumors are not in place, so that some patients find advanced tumors when gastric cancer and gastric malignant tumors are found. when gastric cancer or gastric malignant tumors metastasize other organs, such patients belong to stage IV, and the prognosis is very poor. Objective: To improve the 5-year survival rate of patients with advanced gastric cancer or gastric malignant tumors and improve their quality of life. research on this kind of patient is meaningful. At present, the treatment process of such patients is also very controversial and different. Standardize the treatment process of such patients. Research methods: the number of studies and cases of gastric cancer or malignant tumors transferred to other organs from 2020 to 2023 in CNKI and PubMed public databases, and finally analyzed them. Organs include the brain, lungs, liver and large retina, spleen and pancreas, kidney and uterus, ovaries and vagina, and bone. Inclusion criteria: Gastric cancer or gastric malignant tumors are combined with omental metastasis, brain metastasis, lung metastasis, liver metastasis, spleen metastasis, pancreatic metastasis, kidney metastasis, uterine metastasis, ovarian metastasis and bone metastasis. Results: The most common metastasis of gastric cancer and gastric malignant tumors in this study are the liver and large omentum (76.8%), the brain (16.5%), lungs (2.2%), ovaries and vagina (1.8%), pancreas and spleen (1.3%), but kidneys and uterus (0.8%) and bone (0.6%) are relatively rare. Due to our systemic treatment, the survival rate of patients with straight gastric cancer or gastric malignant tumors has gradually increased, resulting in a gradual increase in tumor metastasis. It is agreed that patients with gastric cancer or gastric malignant tumors transferred to other organs should actively undergo radical tumor resection + tumor extinction + heat perfusion chemotherapy.
| Published in | World Journal of Public Health (Volume 8, Issue 3) |
| DOI | 10.11648/j.wjph.20230803.17 |
| Page(s) | 237-242 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Stage IV Gastric Cancer, Gastric Malignant Tumor, Metastasis, Organs, Standardized Treatment Process, Advanced Tumor
| [1] | Tang Jiadai. Clinical and pathological characteristics and prognosis of gastric cancer metastasis [D]. Kunming Medical University, 2022. DOI: 10.27202/d.cnki.gkmyc.2022.000997. |
| [2] | Xu Huimian, Xu Yan. New progress in the study of gastric cancer metastasis [J]. Chinese Journal of Practical Surgery, 2011, 31 (8): 666-669. |
| [3] | Research progress of Li Qiuhao, Huang Mingwei, Huang Haige. MiRNA in regulating the mechanism of gastric cancer metastasis in the tumor microenvironment [J]. Youjiang Medicine, 2023, 51 (2): 156-159. DOI: 10.3969/j.issn.1003-1383.2023.02.013. |
| [4] | Liang Han. The rules and prevention and treatment strategies of gastric cancer metastasis [J]. Chinese Journal of Basics and Clinical, 2012, 19 (1): 8-11. |
| [5] | Qi Xiangdong, Liu Jinlong, Yuan Jinglun, Chen Guoyu. Clinical diagnosis and treatment of various organs metastasis of gastric cancer [J]. Journal of Nanjing Medical University (Natural Science Edition), 2006, 26 (3): 218-219. DOI: 10.3969/j.issn.1007-4368.2006.03.021. |
| [6] | Su Qianqian, Huang Xinfu, Wang Yi, Xie Yuquan, Li Jiyou. Relationship between gastric cancer metastasis and prognosis and tumor angiogenesis [J]. Chinese Journal of Experimental Surgery, 2002, 19 (4): 306-307. DOI: 10.3760/j.issn:1001-9030.2002.04.008. |
| [7] | Zhang Liangming, Sun Ping. Clinical analysis of meningioma caused by gastric cancer metastasis [J]. Clinical oncology in China, 2005, 32 (20): 1180-1181. DOI: 10.3969/j.issn.1000-8179.2005.20.013. |
| [8] | Chen Zheng, Lao Xuejun. Clinical report on gastric cancer metastasis [J]. Journal of Jinan University (Natural Sciences and Medicine Edition), 2011, 32 (4): 443-444. DOI: 10.3969/j.issn.1000-9965.2011.04.022. |
| [9] | Deng Jinyu, Li Yulin, Yu Zhao, Fan Weixiong. Multi-center control evaluation of MSCT diagnosis of metastatic lymph nodes in gastric cancer and postoperative disease detection [J]. China CT and MRI Magazine, 2015, (4): 97-100. DOI: 10.3969/j.issn.1672-5131.2015.04.31. |
| [10] | Yin Zhuomin, Yu Hua. Clinical analysis of cervical metastasis of gastric cancer and colorectal cancer [J]. Chinese Cancer Journal, 2009, 19 (3): 210-213. DOI: 10.3969/j.issn.1007-3639.2009.03.012. |
| [11] | Zhang Dexi, Xiong Yuanzhi, Ma Guozhong, etc. Clinical analysis of gastric cancer metastasis in the progressive stage of Qinghai Plateau [J]. Journal of Plateau Medicine, (1): 2000, 23-26. |
| [12] | Wu Daohong, Wu Benyan. Advances in early gastric cancer metastasis and minimally invasive treatment under gastroscopy [J]. PLA Journal of Health Medicine, 2006, 8 (2): 117-119. DOI: 10.3969/j.issn.1674-3245.2006.02.029. |
| [13] | Zhu Hangrui, Luo Shiqiao. Current status of surgical treatment of liver metastasis of gastric cancer [J]. Kangyi, 2022, (4): 290-292. DOI: 10.12332/j.issn.2095-6525.2022.04.097. |
| [14] | Lv Chengyu, Shikai Net, Zhang Yunchun. Micrometastasis of gastric cancer and surgical techniques [J]. Journal of Practical Oncology, 2007, 22 (5): 467-470. DOI: 10.3969/j.issn.1001-1692.2007.05.030. |
| [15] | Gao Kun, Ouyang Xiaohui, Liu Ming. Research progress in micrometastasis detection of gastric cancer [J]. 2006, (3). |
| [16] | Yang Wanyong, Du Zongxiao, Fan Ruijun, etc. RT-PCR to detect the prediction of micrometastasis of gastric cancer by CEAmRNA in peripheral blood cancer cells in patients with gastric cancer [J]. 2002, (3). |
| [17] | Zheng Shu, Dong Qi, Chen Yiding. Molecular biological characteristics of tumor cells related to gastrointestinal malignant tumor metastasis and prognosis [J]. 2004, (6). |
| [18] | Wu Chucheng, Yang Jiesheng, Chen Yuping, etc. Advances in the detection of micrometastasis of gastric cancer by RT-PCR method [J]. 2003, (3). |
| [19] | Zhang Xiwei, Fan Ping, Yang Hongyu, etc. Detection of peripheral blood micrometastasis of gastrointestinal malignant tumors and its clinical significance [J]. 2003, (1). |
| [20] | H, Isozaki, K, Okajima, K, Fujii. Histological evaluation of lymph node metastasis on serial sectioning in gastric cancer with radical lymphadenectomy. [J]. 1900, 44 (16). |
| [21] | Yonemura Y, Fushida S, Fujimura T, etc. Diagnostic value of preoperative RT-PCR-based screening method to detect carcinoembryonic antigen-expressing free cancer cells in the peritoneal cavity from patients with gastric cancer. [J]. 2001, 71 (9). |
| [22] | F, Miyazono, S, Natsugoe, S, Takao, etc. Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. [J]. 2001, 233 (2). |
| [23] | T, Fukagawa, M, Sasako, G B, Mann, etc. Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. [J]. 2001, 92 (4). |
| [24] | Y, Okada, Y, Fujiwara, H, Yamamoto, etc. Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay. [J]. 2001, 92 (8). |
| [25] | Iwamoto K, Murata K, Narushima Y, etc. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. [J]. 2004, 39 (4). |
| [26] | Yasuhiro, Kodera, Hayao, Nakanishi, Seiji, Ito, etc. Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. [J]. 2002, 235 (4). |
| [27] | Roggo A, Lukyanchuk VV, Ayuni E, etc. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers. [J]. 2003, 23 (3B). |
| [28] | Komuro A, Yashiro M, Iwata C, etc. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling. [J]. 2009, 101 (8). |
APA Style
Wu Ping Dong, Linda Chiuman, Liena, Liu Chao. (2023). Study and Analysis of Other Tissues and Organs of Gastric Cancer and Gastric Malignant Tumor Metastasis - A Population-Based Study. World Journal of Public Health, 8(3), 237-242. https://doi.org/10.11648/j.wjph.20230803.17
ACS Style
Wu Ping Dong; Linda Chiuman; Liena; Liu Chao. Study and Analysis of Other Tissues and Organs of Gastric Cancer and Gastric Malignant Tumor Metastasis - A Population-Based Study. World J. Public Health 2023, 8(3), 237-242. doi: 10.11648/j.wjph.20230803.17
AMA Style
Wu Ping Dong, Linda Chiuman, Liena, Liu Chao. Study and Analysis of Other Tissues and Organs of Gastric Cancer and Gastric Malignant Tumor Metastasis - A Population-Based Study. World J Public Health. 2023;8(3):237-242. doi: 10.11648/j.wjph.20230803.17
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.wjph.20230803.17,
author = {Wu Ping Dong and Linda Chiuman and Liena and Liu Chao},
title = {Study and Analysis of Other Tissues and Organs of Gastric Cancer and Gastric Malignant Tumor Metastasis - A Population-Based Study},
journal = {World Journal of Public Health},
volume = {8},
number = {3},
pages = {237-242},
doi = {10.11648/j.wjph.20230803.17},
url = {https://doi.org/10.11648/j.wjph.20230803.17},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjph.20230803.17},
abstract = {Research background: At present, gastric cancer or gastric malignant tumors seriously endanger the health of human beings around the world. The main reason is that this do not have enough understanding of stomach cancer and gastric malignant tumors. Don't attach importance to health education. Helicobacter pylori treatment is incomplete, and it is clearly pointed out in the guidelines that some asymptomatic Helicobacter pylori infection do not need treatment. Our prevention measures for gastric cancer and gastric malignant tumors and the promotion of risk factors are insufficient, and the early screening of gastric cancer and gastric malignant tumors are not in place, so that some patients find advanced tumors when gastric cancer and gastric malignant tumors are found. when gastric cancer or gastric malignant tumors metastasize other organs, such patients belong to stage IV, and the prognosis is very poor. Objective: To improve the 5-year survival rate of patients with advanced gastric cancer or gastric malignant tumors and improve their quality of life. research on this kind of patient is meaningful. At present, the treatment process of such patients is also very controversial and different. Standardize the treatment process of such patients. Research methods: the number of studies and cases of gastric cancer or malignant tumors transferred to other organs from 2020 to 2023 in CNKI and PubMed public databases, and finally analyzed them. Organs include the brain, lungs, liver and large retina, spleen and pancreas, kidney and uterus, ovaries and vagina, and bone. Inclusion criteria: Gastric cancer or gastric malignant tumors are combined with omental metastasis, brain metastasis, lung metastasis, liver metastasis, spleen metastasis, pancreatic metastasis, kidney metastasis, uterine metastasis, ovarian metastasis and bone metastasis. Results: The most common metastasis of gastric cancer and gastric malignant tumors in this study are the liver and large omentum (76.8%), the brain (16.5%), lungs (2.2%), ovaries and vagina (1.8%), pancreas and spleen (1.3%), but kidneys and uterus (0.8%) and bone (0.6%) are relatively rare. Due to our systemic treatment, the survival rate of patients with straight gastric cancer or gastric malignant tumors has gradually increased, resulting in a gradual increase in tumor metastasis. It is agreed that patients with gastric cancer or gastric malignant tumors transferred to other organs should actively undergo radical tumor resection + tumor extinction + heat perfusion chemotherapy.},
year = {2023}
}
TY - JOUR T1 - Study and Analysis of Other Tissues and Organs of Gastric Cancer and Gastric Malignant Tumor Metastasis - A Population-Based Study AU - Wu Ping Dong AU - Linda Chiuman AU - Liena AU - Liu Chao Y1 - 2023/09/13 PY - 2023 N1 - https://doi.org/10.11648/j.wjph.20230803.17 DO - 10.11648/j.wjph.20230803.17 T2 - World Journal of Public Health JF - World Journal of Public Health JO - World Journal of Public Health SP - 237 EP - 242 PB - Science Publishing Group SN - 2637-6059 UR - https://doi.org/10.11648/j.wjph.20230803.17 AB - Research background: At present, gastric cancer or gastric malignant tumors seriously endanger the health of human beings around the world. The main reason is that this do not have enough understanding of stomach cancer and gastric malignant tumors. Don't attach importance to health education. Helicobacter pylori treatment is incomplete, and it is clearly pointed out in the guidelines that some asymptomatic Helicobacter pylori infection do not need treatment. Our prevention measures for gastric cancer and gastric malignant tumors and the promotion of risk factors are insufficient, and the early screening of gastric cancer and gastric malignant tumors are not in place, so that some patients find advanced tumors when gastric cancer and gastric malignant tumors are found. when gastric cancer or gastric malignant tumors metastasize other organs, such patients belong to stage IV, and the prognosis is very poor. Objective: To improve the 5-year survival rate of patients with advanced gastric cancer or gastric malignant tumors and improve their quality of life. research on this kind of patient is meaningful. At present, the treatment process of such patients is also very controversial and different. Standardize the treatment process of such patients. Research methods: the number of studies and cases of gastric cancer or malignant tumors transferred to other organs from 2020 to 2023 in CNKI and PubMed public databases, and finally analyzed them. Organs include the brain, lungs, liver and large retina, spleen and pancreas, kidney and uterus, ovaries and vagina, and bone. Inclusion criteria: Gastric cancer or gastric malignant tumors are combined with omental metastasis, brain metastasis, lung metastasis, liver metastasis, spleen metastasis, pancreatic metastasis, kidney metastasis, uterine metastasis, ovarian metastasis and bone metastasis. Results: The most common metastasis of gastric cancer and gastric malignant tumors in this study are the liver and large omentum (76.8%), the brain (16.5%), lungs (2.2%), ovaries and vagina (1.8%), pancreas and spleen (1.3%), but kidneys and uterus (0.8%) and bone (0.6%) are relatively rare. Due to our systemic treatment, the survival rate of patients with straight gastric cancer or gastric malignant tumors has gradually increased, resulting in a gradual increase in tumor metastasis. It is agreed that patients with gastric cancer or gastric malignant tumors transferred to other organs should actively undergo radical tumor resection + tumor extinction + heat perfusion chemotherapy. VL - 8 IS - 3 ER -
Information
Email: